Literature DB >> 19153826

The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene.

Asako Kawaguchi1, Kyosuke Kanai, Yukio Satoh, Chizu Touge, Keiko Nagata, Takeshi Sairenji, Yoshitsugu Inoue.   

Abstract

To study variations of Epstein-Barr virus (EBV), we analyzed the gp350/220 gene for several cell lines and Japanese wild isolates using direct sequencing. The N-terminal region was highly conserved in all EBVs except for Jijoye/P3HR-1 and a few isolates. The variation of the region coincided with EBV types A and B (also referred to as types 1 and 2) and were, respectively, designated as the types a and b. The type A/a was detected in most Japanese cell lines and wild isolates, and was classified as China1 type with latent membrane protein (LMP) 1 gene. The type B/b was detected in only a few wild isolates with the Med and China2 types. The C-terminus had more diversity than the N-terminus and lacked the divergence between types A/a and B/b. The phylogenetic analyses of the gp350/220 and LMP1 genes may suggest a mode of EBV evolution into types A/a and B/b and then to LMP1 subtypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153826     DOI: 10.1007/s11262-008-0323-0

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  45 in total

1.  High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.

Authors:  C Touge; H Agawa; T Sairenji; Y Inoue
Journal:  Arch Virol       Date:  2005-12-16       Impact factor: 2.574

2.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt's lymphoma cell lines based on the sequence of latent membrane protein 1.

Authors:  Kyosuke Kanai; Yukio Satoh; Yuriko Saiki; Haruo Ohtani; Takeshi Sairenji
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

4.  Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome.

Authors:  G Klein; L Dombos
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

5.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

6.  Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.

Authors:  M Higa; T Kinjo; K Kamiyama; T Iwamasa; T Hamada; K Iyama
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

7.  Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene.

Authors:  C Beisel; J Tanner; T Matsuo; D Thorley-Lawson; F Kezdy; E Kieff
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

8.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from Eastern China and Japan.

Authors:  Yun Wang; Kyosuke Kanai; Yukio Satoh; Bing Luo; Takeshi Sairenji
Journal:  Intervirology       Date:  2007-03-14       Impact factor: 1.763

10.  Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma.

Authors:  M J Boyle; W A Sewell; T B Sculley; A Apolloni; J J Turner; C E Swanson; R Penny; D A Cooper
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

View more
  4 in total

1.  Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma.

Authors:  Susanna H Hutajulu; Eveline K Hoebe; Sandra Awm Verkuijlen; Jajah Fachiroh; Bambang Hariwijanto; Sofia M Haryana; Servi Jc Stevens; Astrid E Greijer; Jaap M Middeldorp
Journal:  Infect Agent Cancer       Date:  2010-09-19       Impact factor: 2.965

Review 2.  Epstein-barr virus vaccines.

Authors:  Jeffrey I Cohen
Journal:  Clin Transl Immunology       Date:  2015-01-23

Review 3.  Epstein-barr virus sequence variation-biology and disease.

Authors:  Stelios Tzellos; Paul J Farrell
Journal:  Pathogens       Date:  2012-11-08

4.  Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.

Authors:  Jiang-Bo Zhang; Shao-Yi Huang; Tong-Min Wang; Si-Qi Dong; Yong-Qiao He; Xiao-Hui Zheng; Xi-Zhao Li; Fang Wang; Mu Jianbing; Wei-Hua Jia
Journal:  EBioMedicine       Date:  2018-11-09       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.